PMID: 6106282Jun 1, 1980Paper

Angiotensin II blockade during combined thiazide-beta-blocker treatment

Scandinavian Journal of Clinical and Laboratory Investigation
H IbsenJ Giese

Abstract

Sixteen patients (11 M, 5 F), median age 41 years, with essential hypertension insufficiently controlled on hydrochlorothiazide 75 mg/day (DBP greater than or equal to 100 mmHg) were investigated. Plasma renin concentration (PRC), angiotensin II concentration (PA II), aldosterone concentration (PAC), plasma noradrenaline concentration (PNAC), plasma volume (PV) and exchangeable sodium (NaE) were determined and a saralasin-infusion (5.4 nmol/kg/min) was carried out while the patients were on thiazide alone, and in fourteen cases, repeated 3 months later after addition of a beta-blocker (propranolol 6, metoprolol 6 and atenolol 2 patients). On thiazide alone PRC, PA II and PAC was higher than normal in the group as a whole and the angiotensin II-inhibitor, saralasin, caused a significant decrease in MAP in twelve out of sixteen patients. After addition of a beta-blocker SBP and DBP decreased from 164/109 mmHg to 136/94 mmHg. PRC and PA II decreased by 40% and 58%, respectively. At this point saralasin caused no significant change in MAP. No close correlation was found between changes in BP on beta-blocker treatment and either PRC, PA II or saralasin response on thiazide treatment. PV, NaE, PAC and PNAC did not change sigificantly...Continue Reading

References

May 31, 1976·The American Journal of Medicine·B E Kralberg, K Tolagen
Jan 9, 1975·The New England Journal of Medicine·E L BravoH P Dustan
Jun 5, 1975·The New England Journal of Medicine·W A Pettinger, H C Mitchell
Mar 1, 1978·Circulation Research·E D VaughanC R Ayers
Nov 27, 1978·European Journal of Clinical Pharmacology·H IbsenJ Giese
Jul 8, 1976·The New England Journal of Medicine·J W HollifieldD G Shand
Mar 15, 1976·Clinica Chimica Acta; International Journal of Clinical Chemistry·A M KappelgaardJ Giese
Dec 1, 1970·Scandinavian Journal of Clinical and Laboratory Investigation·J GieseO Munck
Dec 1, 1971·American Heart Journal·R C TaraziH P Dustan
Feb 1, 1972·The Journal of Clinical Endocrinology and Metabolism·A M Michelakis, R G McAllister
Oct 1, 1974·Scandinavian Journal of Clinical and Laboratory Investigation·H Ibsen

❮ Previous
Next ❯

Citations

Jan 1, 1989·Clinical and Experimental Hypertension. Part A, Theory and Practice·P J ManhemJ I Robertson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.